Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease

详细信息    查看全文

• 作者：Lijian Xie ; Renjian Wang ; Min Huang ; Yongwei Zhang ; Jie Shen…
• 关键词：Kawasaki disease ; Myocardial fibrosis ; Cardiac integrated backscatter
• 刊名：Cardiovascular Ultrasound
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：14
• 期：1
• 全文大小：1,122 KB
• 参考文献：1.Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome prevailing in Japan. Pediatrics. 1974;54:271–6.PubMed
  2.Melish ME. Kawasaki syndrome. Pediatr Rev. 1996;17:153–62.PubMed CrossRef
  3.Muzik O, Paridon SM, Singh TP, Morrow WR, Dayanikli F, Di Carli MF. Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography. J Am Coll Cardiol. 1996;28:757–62.PubMed CrossRef
  4.Furuyama H, Odagawa Y, Katoh C, Iwado Y, Yoshinaga K, Ito Y, et al. Assessment of coronary function in children with a history of Kawasaki disease using (15) O-water positron emission tomography. Circulation. 2002;105:2878–84.PubMed CrossRef
  5.Paridon SM, Galioto FM, Vincent JA, Tomassoni TL, Sullivan NM, Bricker JT. Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol. 1995;25:1420–4.PubMed CrossRef
  6.Fukazawa M, Fukushige J, Takeuchi T, Narabayashi H, Igarashi H, Hijii T, et al. Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram. Pediatr Cardiol. 1993;14:67–74.PubMed CrossRef
  7.Yutani C, Go S, Kamiya T, Hirose O, Misawa H, Maeda H, et al. Cardiac biopsy of Kawasaki disease. Arch Pathol Lab Med. 1981;105:470–3.PubMed
  8.Lin MT, Chen SJ, Ho YL, Huang KC, Chen CA, Chiu SN, et al. Abnormal matrix remodeling in adolescents and young adults with Kawasaki disease late after onset. Clinical Chemistry. 2008;54:1815–22.PubMed CrossRef
  9.Numano F, Shimizu C, Jimenez-Fernandez S, Vejar M, Oharaseki T, Takahashi K, et al. Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms. Int J Cardiol. 2015;201:429–37.PubMed CrossRef
  10.Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CG, Mowat AP. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res. 1991;30(3):276–80.PubMed CrossRef
  11.Pérez JE, Miller JG, Holland MR, Wickline SA, Waggoner AD, Barzilai B, et al. Ultrasonic tissue characterization: integrated backscatter imaging for detecting myocardial structural properties and on-line quantitation of cardiac function. Am J Card Imaging. 1994;8:106–12.PubMed
  12.Kosmala W, Przewlocka-Kosmala M, Wojnalowicz A, Mysiak A, Marwick TH. Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction. Eur Heart J Cardiovasc Imaging. 2012;13:459–67.PubMed CrossRef
  13.Leonardi B, Giglio V, Sanders SP, Pasceri V, De Zorzi A. Ultrasound tissue characterization of the myocardium in patients after Kawasaki disease. Pediatr Cardiol. 2010;31:766–72.PubMed CrossRef
  14.Nagata H, Yamamura K, Uike K, Nakashima Y, Hirata Y, Morihana E, et al. Evaluation of echogenicity of the heart in Kawasaki disease. Eur J Pediatr. 2014;173:1089–93.PubMed CrossRef
  15.Abe O, Karasawa K, Hirano M, Miyashita M, Taniguchi K, Ayusawa M, et al. Quantitative evaluation of coronary artery wall echogenicity by integrated backscatter analysis in Kawasaki disease. J Am Soc Echocardiogr. 2010;23:938–42.PubMed CrossRef
  16.Yu JJ, Jang WS, Ko HK, Han MK, Kim YH, Ko JK, et al. Perivascular brightness of coronary arteries in Kawasaki disease. J Pediatr. 2011;159:454–7.PubMed CrossRef
  17.Prior DL, Somaratne JB, Jenkins AJ, Yii M, Newcomb AE, Schalkwijk CG, et al. Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery. Open Heart. 2015;2(1), e000278.PubMed PubMedCentral CrossRef
  18.Newburger JW, Takahashi M, Gerber MA, Han MK, Kim YH, Ko JK, et al. Committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association, American academy of pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association. Circulation. 2004;110:2747–71.PubMed CrossRef
  19.Research Committee on Kawasaki Disease. Report of Subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesion in Kawasaki disease. Japan, Ministry of Health and Welfare: Tokyo; 1984. p. 55–66.
  20.Rhyne TL, Sagar KB. IBR5: an optimal measurement of integrated backscatter and cyclic variation of integrated backscatter. Ultrason Imaging. 1990;12:189–204.PubMed CrossRef
  21.Gong L, Wang ZG, Ran HT, Ling ZY, Tang HL, Zheng YY, et al. Relationship between myocardial ultrasonic integrated backscatter and mitochondria of the myocardium in dogs. Clin Imaging. 2006;30:402–8.PubMed CrossRef
  22.Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, Mysiak A, Marwick TH. Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade. Heart. 2013;99:320–6.PubMed CrossRef
  23.Bertini M, Delgado V, den Uijl DW, Nucifora G, Ng ACT, van Bommel RJ, et al. Prediction of cardiac resynchronization therapy response: value of calibrated integrated backscatter imaging. Circ Cardiovasc Imaging. 2010;3:86–93.PubMed CrossRef
  24.Maceira AM, Barba J, Varo N, Beloqui O, Díez J. Ultrasonic backscatter and serum marker of cardiac fibrosis in hypertensives. Hypertension. 2002;39:923–8.PubMed CrossRef
  25.Yonesaka S, Takahashi T, Matubara T, Nakada T, Furukawa H, Tomimoto K, et al. Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle. Jpn Circ J. 1992;56:352–8.PubMed CrossRef
  26.Yonesaka S, Takahashi T, Eto S, Sato T, Otani K, Ueda T, et al. Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms. Cardiology in the Young. 2010;20:602–9.PubMed CrossRef
  27.Lieback E, Hardouin I, Meyer R, Bellach J, Hetzer R. Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. Eur Heart J. 1996;17:135–42.PubMed CrossRef
  28.Shah RV, Abbasi SA, Neilan TG, Hulten E, Coelho-Filho O, Hoppin A, et al. Myocardial tissue remodeling in adolescent obesity. J Am Heart Assoc. 2013;2, e000279.PubMed PubMedCentral CrossRef
  
• 作者单位：Lijian Xie (1)
  Renjian Wang (1)
  Min Huang (1)
  Yongwei Zhang (1)
  Jie Shen (1)
  Tingting Xiao (1)
  
  1. Department of Cardiology, Shanghai Children’s Hospital, Shanghai Jiaotong University, No. 355 Luding Road, Shanghai, 200062, China
  
• 刊物主题：Ultrasound; Angiology; Cardiology; Imaging / Radiology;
• 出版者：BioMed Central
• ISSN：1476-7120

文摘

Background Kawasaki disease is an acute, systemic vasculitis that affects the coronary arteries. However, the relationship between myocardial fibrosis and Kawasaki disease has been completely unknown until now. We aimed to provide quantitative information about myocardial fibrosis using cardiac integrated backscatter in Han race Kawasaki disease patients.